1. 目次
1.1 表のリスト
1.2 図のリスト
2. バイオロジクスの世界市場レビュー、2024年
2.1 バイオロジクス産業の概要
2.2 調査方法
3. バイオロジクス市場の洞察
3.1 バイオロジクス市場の2034年までの動向
3.2 バイオロジクス市場の将来機会
3.3 バイオロジクスの主要用途（2024年）対2034年
3.4 バイオロジクスの主要タイプ（2024年）対2034年
3.5 バイオロジクス市場の主要エンドユーザー、2024年対2034年
3.6 バイオロジクス市場の有望国：2024年対2034年
4. バイオロジクス市場の動向、促進要因、阻害要因
4.1 バイオロジクス市場の最新動向と最近の動き
4.2 バイオロジクス市場の成長を促進する主な要因
4.2 バイオロジクス産業にとっての主要課題（2025〜2034年
4.3 バイオロジクスのサプライチェーンに対する戦争と地政学的緊張の影響
5 バイオロジクス世界市場のファイブフォース分析
5.1 バイオロジクス産業の魅力指数、2024年
5.2 バイオロジクス市場の新規参入の脅威
5.3 バイオロジクス市場のサプライヤーの交渉力
5.4 バイオロジクス市場の買い手の交渉力
5.5 バイオロジクス市場の競争激化
5.6 バイオロジクス市場における代替品の脅威
6. バイオロジクスの世界市場データ-産業規模、シェア、展望
6.1 バイオロジクス市場の年間売上高展望、2025〜2034年（百万ドル）
6.1 バイオロジクスの世界市場タイプ別年間売上高展望、2025〜2034年（百万ドル）
6.2 バイオロジクスの世界市場用途別年間売上高展望、2025〜2034年（百万ドル）
6.3 バイオロジクスの世界市場：エンドユーザー別年間売上高展望、2025〜2034年（百万ドル）
6.4 バイオロジクスの世界市場：地域別年間売上高展望、2025〜2034年（百万ドル）
7. アジア太平洋地域のバイオロジクス産業統計-市場規模、シェア、競争、展望
7.1 アジア太平洋地域の市場インサイト、2024年
7.2 アジア太平洋地域のバイオロジクス市場のタイプ別収益予測、2025〜2034年（百万米ドル）
7.3 アジア太平洋地域のバイオロジクス市場の用途別収益予測、2025〜2034年（USD Million）
7.4 アジア太平洋地域のバイオロジクス市場のエンドユーザー別収益予測、2025〜2034年（USD Million）
7.5 アジア太平洋地域のバイオロジクス市場の国別収益予測、2025〜2034年（USD Million）
7.5.1 中国 バイオロジクスの分析と2034年までの予測
7.5.2 日本 バイオロジクスの分析と2034年までの予測
7.5.3 インド バイオロジクスの分析と2034年までの予測
7.5.4 韓国のバイオロジクスの分析と2034年までの予測
7.5.5 オーストラリアのバイオロジクスの分析と2034年までの予測
7.5.6 インドネシアのバイオロジクスの分析と2034年までの予測
7.5.7 マレーシアのバイオロジクスの分析と2034年までの展望
7.5.8 ベトナムのバイオロジクスの分析と2034年までの展望
7.6 アジア太平洋バイオロジクス産業の主要企業
8. ヨーロッパバイオロジクス市場の歴史的動向、展望、ビジネス展望
8.1 ヨーロッパの主要調査結果、2024年
8.2 ヨーロッパのバイオロジクス市場規模およびタイプ別構成比、2025〜2034年（百万米ドル）
8.3 ヨーロッパのバイオロジクス市場規模および用途別構成比、2025〜2034年（百万米ドル）
8.4 ヨーロッパのバイオロジクス市場規模およびエンドユーザー別構成比、2025〜2034年 （百万米ドル）
8.5 ヨーロッパのバイオロジクス市場規模および国別構成比、2025〜2034年 （百万米ドル）
8.5.1 2024年ドイツのバイオロジクス市場規模推移と2034年までの展望
8.5.2 2024年 イギリスのバイオロジクス市場規模推移と2034年までの展望
8.5.3 2024年 フランスバイオロジクス市場の規模及び2034年までの展望
8.5.4 2024年イタリアのバイオロジクス市場の規模と2034年までの展望
8.5.5 2024年スペインのバイオロジクス市場の規模と2034年までの展望
8.5.6 2024年ベネルクスバイオロジクス市場の規模推移と2034年までの展望
8.5.7 2024年ロシアのバイオロジクス市場の規模及び2034年までの展望
8.6 ヨーロッパバイオロジクス産業の主要企業
9. 北アメリカバイオロジクス市場の動向・展望・成長展望
9.1 北アメリカのスナップショット（2024年）
9.2 北アメリカのバイオロジクス市場のタイプ別分析と展望、2025〜2034年（$ Million）
9.3 北アメリカのバイオロジクス市場の用途別分析と展望、2025〜2034年（$ Million）
9.4 北アメリカのバイオロジクス市場の分析と展望：エンドユーザー別、2025〜2034年（$ Million）
9.5 北アメリカのバイオロジクス市場の国別分析と展望、2025〜2034年（$ Million）
9.5.1 アメリカのバイオロジクス市場の分析と展望
9.5.2 カナダのバイオロジクス市場の分析と展望
9.5.3 メキシコバイオロジクス市場の分析と展望
9.6 北アメリカバイオロジクス事業の主要企業
10. 中南アメリカのバイオロジクス市場の促進要因、課題、成長展望
10.1 中南アメリカのスナップショット（2024年）
10.2 ラテンアメリカのバイオロジクス市場のタイプ別将来、2025〜2034年（$ Million）
10.3 ラテンアメリカのバイオロジクス市場の用途別将来、2025〜2034年（$ Million）
10.4 ラテンアメリカのバイオロジクス市場の将来：エンドユーザー別、2025〜2034年（$ Million）
10.5 ラテンアメリカのバイオロジクス市場の国別将来、2025〜2034年（$ Million）
10.5.1 ブラジルのバイオロジクス市場の分析と2034年までの展望
10.5.2 アルゼンチンのバイオロジクス市場の分析と2034年までの展望
10.5.3 チリのバイオロジクス市場の分析と2034年までの展望
10.6 ラテンアメリカバイオロジクス産業の主要企業
11. 中東アフリカバイオロジクス市場の展望と成長展望
11.1 中東アフリカの概要、2024年
11.2 中東アフリカバイオロジクス市場のタイプ別統計（2025〜2034年：百万米ドル）
11.3 中東アフリカバイオロジクス市場の用途別統計：2025〜2034年（百万米ドル）
11.4 中東アフリカバイオロジクス市場のエンドユーザー別統計：2025年〜2034年 （百万米ドル）
11.5 中東アフリカバイオロジクスの国別市場統計：2025〜2034年 （百万米ドル）
11.5.1 南アフリカのバイオロジクス市場の展望
11.5.2 エジプトバイオロジクス市場の展望
11.5.3 サウジアラビアのバイオロジクス市場の展望
11.5.4 イランバイオロジクス市場の展望
11.5.5 UAEバイオロジクス市場の展望
11.6 中東アフリカバイオロジクス事業の主要企業
12. バイオロジクス市場の構造と競争環境
12.1 バイオロジクス事業の主要企業
12.2 バイオロジクス主要企業のベンチマーキング
12.3 バイオロジクスの製品ポートフォリオ
12.4 財務分析
12.5 SWOTと財務分析レビュー
14. バイオロジクス市場の最新ニュース、取引、動向
14.1 バイオロジクスの貿易輸出、輸入額と価格分析
15 付録
15.1 出版社の専門知識
15.2 バイオロジクス産業レポートの情報源と方法論
The biologics market is experiencing a period of rapid growth and transformation, driven by the increasing demand for innovative and targeted therapies for a wide range of diseases. Biologics, which are complex molecules derived from living organisms, offer a new generation of therapeutic options that have revolutionized the treatment of various conditions, from cancer and autoimmune disorders to infectious diseases and genetic conditions. These therapies often exhibit greater efficacy and target specificity compared to traditional small-molecule drugs, leading to improved patient outcomes and a shift towards more personalized medicine. In 2024, the biologics market witnessed significant progress with the approval of new biologic drugs, the increasing adoption of biosimilars, and the continued development of innovative therapeutic modalities like cell and gene therapies. This growth reflected a growing understanding of the potential of biologics to address unmet medical needs and improve healthcare outcomes.
Looking ahead to 2025, the biologics market is poised for continued robust expansion. The increasing prevalence of chronic diseases, the growing awareness of personalized medicine, and the ongoing research into new therapeutic targets are all expected to fuel market growth. The market is likely to see a greater emphasis on the development of biosimilars, providing more affordable alternatives to existing biologics and expanding access to these innovative therapies. Furthermore, the increasing adoption of cell and gene therapies, which offer the potential for targeted and curative treatments for various diseases, is expected to create new avenues for growth within the biologics market. However, the industry will also face challenges related to the complexities of biologics manufacturing, the need for robust clinical trial data to support regulatory approval, and the evolving regulatory landscape. The biologics market is therefore at a crucial juncture, balancing the potential for transformative therapies with the need for rigorous scientific research, regulatory compliance, and ethical considerations.
The Global Biologics Market Analysis Report will provide a comprehensive assessment of business dynamics, offering detailed insights into how companies can navigate the evolving landscape to maximize their market potential through 2034. This analysis will be crucial for stakeholders aiming to align with the latest industry trends and capitalize on emerging market opportunities.
Biologics Market Strategy, Price Trends, Drivers, Challenges and Opportunities to 2034
In terms of market strategy, price trends, drivers, challenges, and opportunities from2025 to 2034, Biologics market players are directing investments toward acquiring new technologies, securing raw materials through efficient procurement and inventory management, enhancing product portfolios, and leveraging capabilities to sustain growth amidst challenging conditions. Regional-specific strategies are being emphasized due to highly varying economic and social challenges across countries.
Factors such as global economic slowdown, the impact of geopolitical tensions, delayed growth in specific regions, and the risks of stagflation necessitate a vigilant and forward-looking approach among Biologics industry players. Adaptations in supply chain dynamics and the growing emphasis on cleaner and sustainable practices further drive strategic shifts within companies.
The market study delivers a comprehensive overview of current trends and developments in the Biologics industry, complemented by detailed descriptive and prescriptive analyses for insights into the market landscape until 2034.
North America Biologics Market Analysis
The North America Biologics market demonstrated robust growth in 2024, driven by advancements in personalized medicine, the proliferation of digital health solutions, and increased investment in biotechnologies such as biosimilars, biologics CDMO, and AI-driven medical diagnostics. The market is set to expand further in 2025, with a healthy CAGR driven by the rise in chronic disease incidence, aging demographics, and government initiatives supporting pharmaceutical innovation. Other notable growth drivers to 2034 include advancements in therapeutics and diagnostics, including biomarkers and gene therapy, as well as expanding applications of AI in drug discovery and clinical decision-making. Regulatory approvals and strategic partnerships between key players are enabling faster commercialization of cutting-edge therapies and medical technologies. This Biologics market growth trajectory reflects a dynamic market landscape, with innovation, demand for digital transformation, and regulatory adaptation playing pivotal roles.
Europe Biologics Market Outlook
The European Biologics market witnessed steady growth in 2024, underpinned by increased funding for healthcare innovation, robust R&D, and the adoption of advanced diagnostic solutions. The Biologics market is projected to continue growth in 2025, driven by the region's aging population and rising prevalence of autoimmune diseases. Key trends include the expansion of biostimulants and biotechnology, enhanced clinical trial imaging, and the adoption of AI-based diagnostic tools. Government policies promoting digital transformation in healthcare and incentives for eco-friendly medical plastics further support market expansion. Europe remains a hub for groundbreaking innovations, with collaborative frameworks facilitating faster regulatory approvals and market entry.
Asia-Pacific Biologics Market Forecast
Asia-Pacific’s Biologics market emerged as a high-growth region in 2024, driven by escalating demand for affordable healthcare solutions, rapid advancements in biotechnology, and the integration of AI in drug discovery and diagnostics. The Biologics market is poised for exponential growth from 2025 to 2034, supported by increasing healthcare expenditure, a rising middle class, and government initiatives fostering local manufacturing of biosimilars and biologics. Expansion in therapeutics, cell therapy, and autoimmune disease diagnostics underscores the region's focus on precision medicine. Key markets such as China, India, and Japan are spearheading innovation, bolstered by favorable policies and global collaborations. The region’s adoption of digital therapeutics and clinical trial technologies marks a transformative phase, positioning Asia-Pacific as a critical player in the global Biologics market landscape.
Rest of World Biologics Market Future
The Biologics market across Middle East, Africa and South America displayed notable growth in 2024, particularly in emerging economies fueled by improving healthcare infrastructure and rising pharmaceutical investments. Growth from 2025 to 2034 is expected to accelerate, driven by increasing demand for affordable diagnostics, biosimilars, and vaccines to combat infectious and chronic diseases. Countries in the Middle East, Africa, and South America are witnessing significant advancements in areas like antimicrobial susceptibility testing, digital health solutions, and medical plastics. Government-led healthcare reforms, international partnerships, and a focus on localized production are key growth enablers. Additionally, the uptake of AI-driven diagnostics, eClinical solutions, and cancer therapeutics signals a shift towards innovative healthcare delivery. These trends highlight the potential of RoW markets as pivotal contributors to global healthcare evolution.
Biologics Market Dynamics and Future Analytics
The research analyses the Biologics parent market, derived market, intermediaries’ market, raw material market, and substitute market are all evaluated to better prospect the Biologics market outlook. Geopolitical analysis, demographic analysis, and Porter’s five forces analysis are prudently assessed to estimate the best Biologics market projections.
Recent deals and developments are considered for their potential impact on Biologics's future business. Other metrics analyzed include the Threat of New Entrants, Threat of New Substitutes, Product Differentiation, Degree of Competition, Number of Suppliers, Distribution Channel, Capital Needed, Entry Barriers, Govt. Regulations, Beneficial Alternative, and Cost of Substitute in Biologics market.
Biologics trade and price analysis helps comprehend Biologics's international market scenario with top exporters/suppliers and top importers/customer information. The data and analysis assist our clients in planning procurement, identifying potential vendors/clients to associate with, understanding Biologics price trends and patterns, and exploring new Biologics sales channels. The research will be updated to the latest month to include the impact of the latest developments such as the Russia-Ukraine war on the Biologics market.
Biologics Market Structure, Competitive Intelligence and Key Winning Strategies
The report presents detailed profiles of top companies operating in the Biologics market and players serving the Biologics value chain along with their strategies for the near, medium, and long term period.
OGAnalysis’ proprietary company revenue and product analysis model unveils the Biologics market structure and competitive landscape. Company profiles of key players with a business description, product portfolio, SWOT analysis, Financial Analysis, and key strategies are covered in the report. It identifies top-performing Biologics products in global and regional markets. New Product Launches, Investment & Funding updates, Mergers & Acquisitions, Collaboration & Partnership, Awards and Agreements, Expansion, and other developments give our clients the Biologics market update to stay ahead of the competition.
Company offerings in different segments across Asia-Pacific, Europe, the Middle East, Africa, and South and Central America are presented to better understand the company strategy for the Biologics market. The competition analysis enables users to assess competitor strategies and helps align their capabilities and resources for future growth prospects to improve their market share.
Biologics Market Research Scope
• Global Biologics market size and growth projections (CAGR), 2024- 2034
• Policies of USA New President Trump, Russia-Ukraine War, Israel-Palestine, Middle East Tensions Impact on the Biologics Trade and Supply-chain
• Biologics market size, share, and outlook across 5 regions and 27 countries, 2023- 2034
• Biologics market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2023- 2034
• Short and long-term Biologics market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, Technological developments in the Biologics market, Biologics supply chain analysis
• Biologics trade analysis, Biologics market price analysis, Biologics supply/demand
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products
• Latest Biologics market news and developments
The Biologics Market international scenario is well established in the report with separate chapters on North America Biologics Market, Europe Biologics Market, Asia-Pacific Biologics Market, Middle East and Africa Biologics Market, and South and Central America Biologics Markets. These sections further fragment the regional Biologics market by type, application, end-user, and country.
Countries Covered
North America Biologics market data and outlook to 2034
United States
Canada
Mexico
Europe Biologics market data and outlook to 2034
Germany
United Kingdom
France
Italy
Spain
BeNeLux
Russia
Asia-Pacific Biologics market data and outlook to 2034
China
Japan
India
South Korea
Australia
Indonesia
Malaysia
Vietnam
Middle East and Africa Biologics market data and outlook to 2034
Saudi Arabia
South Africa
Iran
UAE
Egypt
South and Central America Biologics market data and outlook to 2034
Brazil
Argentina
Chile
Peru
* We can include data and analysis of additional coutries on demand
[Who can benefit from this research]
The research would help top management/strategy formulators/business/product development/sales managers and investors in this market in the following ways
1. The report provides 2024 Biologics market sales data at the global, regional, and key country levels with a detailed outlook to 2034 allowing companies to calculate their market share and analyze prospects, uncover new markets, and plan market entry strategy.
2. The research includes the Biologics market split into different types and applications. This segmentation helps managers plan their products and budgets based on the future growth rates of each segment
3. The Biologics market study helps stakeholders understand the breadth and stance of the market giving them information on key drivers, restraints, challenges, and growth opportunities of the market and mitigating risks
4. This report would help top management understand competition better with a detailed SWOT analysis and key strategies of their competitors, and plan their position in the business
5. The study assists investors in analyzing Biologics business prospects by region, key countries, and top companies' information to channel their investments.
[Available Customizations]
The standard syndicate report is designed to serve the common interests of Biologics Market players across the value chain and include selective data and analysis from entire research findings as per the scope and price of the publication.
However, to precisely match the specific research requirements of individual clients, we offer several customization options to include the data and analysis of interest in the final deliverable.
Some of the customization requests are as mentioned below –
Segmentation of choice – Our clients can seek customization to modify/add a market division for types/applications/end-uses/processes of their choice.
Biologics Pricing and Margins Across the Supply Chain, Biologics Price Analysis / International Trade Data / Import-Export Analysis,
Supply Chain Analysis, Supply – Demand Gap Analysis, PESTLE Analysis, Macro-Economic Analysis, and other Biologics market analytics
Processing and manufacturing requirements, Patent Analysis, Technology Trends, and Product Innovations
Further, the client can seek customization to break down geographies as per their requirements for specific countries/country groups such as South East Asia, Central Asia, Emerging and Developing Asia, Western Europe, Eastern Europe, Benelux, Emerging and Developing Europe, Nordic countries, North Africa, Sub-Saharan Africa, Caribbean, The Middle East and North Africa (MENA), Gulf Cooperation Council (GCC) or any other.
Capital Requirements, Income Projections, Profit Forecasts, and other parameters to prepare a detailed project report to present to Banks/Investment Agencies.
Customization of up to 10% of the content can be done without any additional charges.
Note: Latest developments will be updated in the report and delivered within 2 to 3 working days
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Biologics Market Review, 2024
2.1 Biologics Industry Overview
2.2 Research Methodology
3. Biologics Market Insights
3.1 Biologics Market Trends to 2034
3.2 Future Opportunities in Biologics Market
3.3 Dominant Applications of Biologics, 2024 Vs 2034
3.4 Key Types of Biologics, 2024 Vs 2034
3.5 Leading End Uses of Biologics Market, 2024 Vs 2034
3.6 High Prospect Countries for Biologics Market, 2024 Vs 2034
4. Biologics Market Trends, Drivers, and Restraints
4.1 Latest Trends and Recent Developments in Biologics Market
4.2 Key Factors Driving the Biologics Market Growth
4.2 Major Challenges to the Biologics industry, 2025- 2034
4.3 Impact of Wars and geo-political tensions on Biologics supply chain
5 Five Forces Analysis for Global Biologics Market
5.1 Biologics Industry Attractiveness Index, 2024
5.2 Biologics Market Threat of New Entrants
5.3 Biologics Market Bargaining Power of Suppliers
5.4 Biologics Market Bargaining Power of Buyers
5.5 Biologics Market Intensity of Competitive Rivalry
5.6 Biologics Market Threat of Substitutes
6. Global Biologics Market Data – Industry Size, Share, and Outlook
6.1 Biologics Market Annual Sales Outlook, 2025- 2034 ($ Million)
6.1 Global Biologics Market Annual Sales Outlook by Type, 2025- 2034 ($ Million)
6.2 Global Biologics Market Annual Sales Outlook by Application, 2025- 2034 ($ Million)
6.3 Global Biologics Market Annual Sales Outlook by End-User, 2025- 2034 ($ Million)
6.4 Global Biologics Market Annual Sales Outlook by Region, 2025- 2034 ($ Million)
7. Asia Pacific Biologics Industry Statistics – Market Size, Share, Competition and Outlook
7.1 Asia Pacific Market Insights, 2024
7.2 Asia Pacific Biologics Market Revenue Forecast by Type, 2025- 2034 (USD Million)
7.3 Asia Pacific Biologics Market Revenue Forecast by Application, 2025- 2034(USD Million)
7.4 Asia Pacific Biologics Market Revenue Forecast by End-User, 2025- 2034 (USD Million)
7.5 Asia Pacific Biologics Market Revenue Forecast by Country, 2025- 2034 (USD Million)
7.5.1 China Biologics Analysis and Forecast to 2034
7.5.2 Japan Biologics Analysis and Forecast to 2034
7.5.3 India Biologics Analysis and Forecast to 2034
7.5.4 South Korea Biologics Analysis and Forecast to 2034
7.5.5 Australia Biologics Analysis and Forecast to 2034
7.5.6 Indonesia Biologics Analysis and Forecast to 2034
7.5.7 Malaysia Biologics Analysis and Forecast to 2034
7.5.8 Vietnam Biologics Analysis and Forecast to 2034
7.6 Leading Companies in Asia Pacific Biologics Industry
8. Europe Biologics Market Historical Trends, Outlook, and Business Prospects
8.1 Europe Key Findings, 2024
8.2 Europe Biologics Market Size and Percentage Breakdown by Type, 2025- 2034 (USD Million)
8.3 Europe Biologics Market Size and Percentage Breakdown by Application, 2025- 2034 (USD Million)
8.4 Europe Biologics Market Size and Percentage Breakdown by End-User, 2025- 2034 (USD Million)
8.5 Europe Biologics Market Size and Percentage Breakdown by Country, 2025- 2034 (USD Million)
8.5.1 2024 Germany Biologics Market Size and Outlook to 2034
8.5.2 2024 United Kingdom Biologics Market Size and Outlook to 2034
8.5.3 2024 France Biologics Market Size and Outlook to 2034
8.5.4 2024 Italy Biologics Market Size and Outlook to 2034
8.5.5 2024 Spain Biologics Market Size and Outlook to 2034
8.5.6 2024 BeNeLux Biologics Market Size and Outlook to 2034
8.5.7 2024 Russia Biologics Market Size and Outlook to 2034
8.6 Leading Companies in Europe Biologics Industry
9. North America Biologics Market Trends, Outlook, and Growth Prospects
9.1 North America Snapshot, 2024
9.2 North America Biologics Market Analysis and Outlook by Type, 2025- 2034($ Million)
9.3 North America Biologics Market Analysis and Outlook by Application, 2025- 2034($ Million)
9.4 North America Biologics Market Analysis and Outlook by End-User, 2025- 2034($ Million)
9.5 North America Biologics Market Analysis and Outlook by Country, 2025- 2034($ Million)
9.5.1 United States Biologics Market Analysis and Outlook
9.5.2 Canada Biologics Market Analysis and Outlook
9.5.3 Mexico Biologics Market Analysis and Outlook
9.6 Leading Companies in North America Biologics Business
10. Latin America Biologics Market Drivers, Challenges, and Growth Prospects
10.1 Latin America Snapshot, 2024
10.2 Latin America Biologics Market Future by Type, 2025- 2034($ Million)
10.3 Latin America Biologics Market Future by Application, 2025- 2034($ Million)
10.4 Latin America Biologics Market Future by End-User, 2025- 2034($ Million)
10.5 Latin America Biologics Market Future by Country, 2025- 2034($ Million)
10.5.1 Brazil Biologics Market Analysis and Outlook to 2034
10.5.2 Argentina Biologics Market Analysis and Outlook to 2034
10.5.3 Chile Biologics Market Analysis and Outlook to 2034
10.6 Leading Companies in Latin America Biologics Industry
11. Middle East Africa Biologics Market Outlook and Growth Prospects
11.1 Middle East Africa Overview, 2024
11.2 Middle East Africa Biologics Market Statistics by Type, 2025- 2034 (USD Million)
11.3 Middle East Africa Biologics Market Statistics by Application, 2025- 2034 (USD Million)
11.4 Middle East Africa Biologics Market Statistics by End-User, 2025- 2034 (USD Million)
11.5 Middle East Africa Biologics Market Statistics by Country, 2025- 2034 (USD Million)
11.5.1 South Africa Biologics Market Outlook
11.5.2 Egypt Biologics Market Outlook
11.5.3 Saudi Arabia Biologics Market Outlook
11.5.4 Iran Biologics Market Outlook
11.5.5 UAE Biologics Market Outlook
11.6 Leading Companies in Middle East Africa Biologics Business
12. Biologics Market Structure and Competitive Landscape
12.1 Key Companies in Biologics Business
12.2 Biologics Key Player Benchmarking
12.3 Biologics Product Portfolio
12.4 Financial Analysis
12.5 SWOT and Financial Analysis Review
14. Latest News, Deals, and Developments in Biologics Market
14.1 Biologics trade export, import value and price analysis
15 Appendix
15.1 Publisher Expertise
15.2 Biologics Industry Report Sources and Methodology
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
